Excited to share the groundbreaking panel led by my good old friend Sandro Cesaro, whose recent post on the transformative power of #artificialintelligence in the healthcare supply chain has resonated deeply with us at MArS Market Access & Pricing Strategy GmbH. Sandro's insights not only highlight the pivotal role of AI in enhancing market access and reimbursement strategies but also underscore the broader vision we share for the future of healthcare innovation. As we navigate the journey towards "Market Access 4.0," we're thrilled to introduce two avant-garde AI platforms that stand at the forefront of this evolution: mAxInsights and our next-generation virtual reality platform, "Wafle", equipped with a cutting-edge closed language model. These platforms are designed to revolutionize early reimbursement planning by providing deeper, more nuanced insights than ever before. mAxInsights leverages AI to dissect complex reimbursement landscapes, offering predictions and strategic recommendations that are tailored to the unique needs of healthcare companies and investors. Meanwhile, our virtual reality platform offers an immersive experience that bridges the gap between digital innovation and human-centric healthcare training. The anticipation builds as we prepare for the official launch of these platforms at the US conference of ISPOR—The Professional Society for Health Economics and Outcomes Research in May 2024. This event marks a significant milestone in our journey, and we're eager to showcase how our latest advancements can redefine market access and create a more agile, responsive healthcare ecosystem. Stay tuned for what promises to be a pivotal moment in healthcare innovation. The future is bright, and it's powered by AI. Watch out!! #HealthcareInnovation #MarketAccess4.0 #ArtificialIntelligence #mAxInsights #VirtualReality #ISPOR2024 #HealthcareTechnology https://lnkd.in/eVQiznXR
Today I had the pleasure of chairing and moderating a pivotal keynote panel discussion on 'Ways that AI can transform Market Access' at the Word Evidence Pricing & Access conference in Amsterdam. Joined by a dynamic group of industry leading experts as well as the payer and provider sector, we delved into the transformative potential of AI across the market access value chain. The depth of knowledge and range of perspectives shared were truly enlightening. Key Highlights: - Use cases along the market access value chain: The discussion spanned an array of use cases, from patient subgroup identification, AI-aided RWE data collection, to HE modelling, dossier writing and all the way to pricing predictive analytics and outcomes management. - Organization and data privacy: The group discussed the critical skills and rapidly evolving requirements for professionals working at the intersection of AI and market access (“You don’t get replaced by AI, but by people using AI”). Navigating data privacy and ethical considerations when using AI are critical too. - Building momentum: Going from use case to scale will likely include both, smaller pilots that can build short-term learnings across the organization with minimal disruption to the business, as well as use cases with longer-term objectives that are potentially more transformational. Undeniably, AI is set to revolutionize parts of the market access value chain. A big thank you to our panelists and the audience for engaging in such a forward-thinking conversation. Rogerio RibeiroSaira A. JanAlexander Bastian Chris Mancill
Head of Market Access & Innovative Value Strategies, Oncology Europe
7moStefan, good use cases of AI-aided virtual reality platforms.